8-K

                          UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C. 20549


                            FORM 8-K


                         CURRENT REPORT

             Pursuant to Section 13 or 15(d) of the

                 Securities Exchange Act of 1934

  Date of Report (Date of earliest event reported) December 15, 2003


                 COMPETITIVE TECHNOLOGIES, INC.
     (Exact name of registrant as specified in its charter)



Delaware                 1-8696                   36-2664428
(State or other          (Commission File         (IRS Employer
jurisdiction             Number)                  Identification No.
of incorporation)




1960 Bronson Road, Fairfield, Connecticut         06824
(Address of principal executive offices)         (Zip Code)



Registrant's  telephone number, including area code   (203)  255-6044



Item 12.  Results of Operations and Financial Condition.

     On December 15, 2003, Competitive Technologies, Inc. (CTT)
announced its fiscal results for the three months ended October
31, 2003.  A copy of CTT's press release is attached hereto as
Exhibit 99.1 and is incorporated by reference herein.

      The information in this Current Report on Form 8-K and the
attached exhibit is furnished pursuant to Item 12 and shall not
be deemed to be "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject
to the liability of that section.





                           Signatures


      Pursuant to the requirements of the Securities Exchange Act
of  1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.


                                   COMPETITIVE TECHNOLOGIES, INC.
                                   Registrant


Date:    December   15,  2003             /s/    John   B.   Nano
                                          By:  John B. Nano
                                          President,
                                          Chief Executive Officer and
                                          Authorized Signer




Exhibit Index

     99.1 Press release dated December 15, 2003.        3-5

EX-99.1

                                                     Exhibit 99.1
For Immediate Release:

                COMPETITIVE TECHNOLOGIES REPORTS
                FIRST QUARTER FISCAL 2004 PROFITS

Fairfield, CT - (December 15, 2003) - Competitive Technologies,
Inc. (AMEX: CTT) today announced profitable results for its
fiscal first quarter for the three months ended October 31, 2003.

Revenues for first quarter of fiscal 2004 increased to $1.3
million compared with $0.4 million for first quarter of fiscal
2003.  Revenues in the first quarter of fiscal 2004 include $0.9
million from CTT's sale of a portion of its potential award in
the Materna litigation.

CTT's net income for first quarter of fiscal 2004 was $0.3
million, compared with the net income for first quarter of fiscal
2003 of $0.8 million.  Excluding a one-time accounts payable
reversal of $1.6 million for patent litigation fees, the first
quarter fiscal 2003 would have shown a net loss of $0.8 million.

"First quarter results reflect the progress we are making towards
our business plan objective of profitability in 2004," said John
B. Nano, CTT's President and CEO.  "Revenues are up for first
quarter fiscal 2004 versus 2003, including a substantial increase
in homocysteine assay royalties partially offset by declines from
payment timing of Ethyol royalties and expired B12 patents.
CTT's new business development team continues to proactively
market our portfolio of recently acquired innovative technologies
including bone biomaterial, wound sealant, language-mastering
software, silicon carbide wafer testing, fuel additives,
pollution abatement, insulated concrete forms and automotive
safety sensors."

Mr. Nano continued, "Our team is creating solid relationships
with both customers and clients in an environment where the
strong trend for companies to license technologies from other
sources validates CTT's business strategy for creating
shareholder value."

About Competitive Technologies, Inc.

Competitive Technologies, established in 1968, is a full service
technology transfer and licensing provider focused on the
technology needs of its customers and transforming those
requirements into commercially viable solutions.  CTT is a global
leader in identifying, developing and commercializing innovative
technologies in life, digital, nano, and physical sciences
developed by universities, companies and inventors.  The global
market for technology transfer services is estimated at $150
billion annually.  CTT maximizes the value of intellectual assets
for the benefit of its customers, clients and shareholders.
Visit CTT's website:  http://www.competitivetech.net

Statements about the Company's future expectations, including
development and regulatory plans, and all other statements in
this document other than historical facts are "forward-looking
statements" within the meaning of applicable Federal Securities
Laws and are not guarantees of future performance.  These
statements involve risks and uncertainties, including those set
forth in Item 1 of the Company's most recent Form 10-K and in
CTT's other filings with the SEC, and are subject to change at
any time.  The Company's actual results could differ materially
from these forward-looking statements.  The Company undertakes no
obligation to update publicly any forward-looking statement.

Direct inquiries to:    Johnnie D. Johnson, Strategic IR,Inc.

                         E-mail: jdjohnson@strategic-ir.com
                         Tel. (212) 754-6565;
                         Fax (212) 754-4333
                         E-mail: ctt@competitivetech.net





                 COMPETITIVE TECHNOLOGIES, INC.
                        AND SUBSIDIARIES

                    FIRST QUARTER FISCAL 2004

          CONDENSED CONSOLIDATED RESULTS OF OPERATIONS
        (dollars in thousands, except per share amounts)
                           (unaudited)

                                        Quarter Ended October 31,
                                                 2003       2002
     Revenue
                                      $      1,287   $       382

     Operating expenses                      1,018         1,199
     Reversal of accounts payable
       exchanged for contingent note                      (1,583)
       payable
     Total operating expenses, net (a)       1,018          (384)



     Operating income (a)             $        269   $       766

     Net income (a)                   $        345   $       779

     Net income per share:
       Basic and diluted (a)          $       0.06   $      0.13

     Weighted average number of
       common shares outstanding:
         Basic (000)                         6,201         6,154
         Diluted (000)                       6,201         6,200


                                         At October   At July 31
                                               2003         2003
     Other Financial D
       Cash and cash equivalents      $       2,400  $     1,405
       Short-term investments         $         100  $       100
       Total assets                   $       3,184  $     2,952

       Total liabilities              $       1,669  $     1,783

       Shareholders' equity           $       1,515  $     1,169

      (a)  Excluding last year's October 31, 2002 accounts payable
          reversal of $1,583 for patent litigation fees, 2002 amounts would
          have been:  Total operating expenses $1,199, Operating loss
          $(817), Net loss $(805), and Net loss per share $(0.13).